PlainRecalls
FDA Drug Low Class III Terminated

Meclizine Hydrochloride Tablets, USP, 12.5 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-034-01) and b) 1000 Ct Bottles (NDC: 49884-034-10), Rx only. Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.

Reported: November 25, 2015 Initiated: October 26, 2015 #D-0233-2016

Product Description

Meclizine Hydrochloride Tablets, USP, 12.5 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-034-01) and b) 1000 Ct Bottles (NDC: 49884-034-10), Rx only. Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for impurities.

Details

Recalling Firm
Par Pharmaceutical Inc.
Units Affected
a) 162,385 Bottles; b) 6949 Bottles
Distribution
U.S. Nationwide including Puerto Rico
Location
Spring Valley, NY

Frequently Asked Questions

What product was recalled?
Meclizine Hydrochloride Tablets, USP, 12.5 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-034-01) and b) 1000 Ct Bottles (NDC: 49884-034-10), Rx only. Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.. Recalled by Par Pharmaceutical Inc.. Units affected: a) 162,385 Bottles; b) 6949 Bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 25, 2015. Severity: Low. Recall number: D-0233-2016.